Search

Your search keyword '"Spital, Georg"' showing total 316 results

Search Constraints

Start Over You searched for: Author "Spital, Georg" Remove constraint Author: "Spital, Georg"
316 results on '"Spital, Georg"'

Search Results

6. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials

7. Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

9. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

11. Interpretation of SD-OCT imaging data in real-life conditions versus standardized reading centre analysis in eyes with diabetic macular oedema or macular oedema secondary to retinal vein occlusion: 24-month follow-up of the ORCA study.

14. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

20. Resolving the dark matter of ABCA4 for 1054 Stargardt disease probands through integrated genomics and transcriptomics

22. Faricimab Treat-and-Extend for Diabetic Macular Edema

23. Initiale Diagnostik und Indikationsstellung zur Anti-Vascular-Endothelial Growth-Factor-Therapie bei Netzhauterkrankungen: Vergleich der Befundung durch Studienarzt versus Reading Center (ORCA/OCEAN-Studie)

25. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

28. Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

35. Fotobasierte Untersuchung auf diabetische Augenveränderungen in einer deutschen Augenarztpraxis ohne direkten Arzt-Patienten-Kontakt

36. Laser Coagulation in AMD

37. Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization

38. Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or combination therapy - The non-interventional second year follow-up to the PRIDE study

39. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

40. Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study

44. High-Throughput Sequencing to Identify Mutations Associated with Retinal Dystrophies

49. Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or combination therapy – The non‐interventional second year follow‐up to the PRIDE study

50. Implementing standardization in imaging-A plea for the Digital Imaging and Communication in Medicine (DICOM) standard in ophthalmology

Catalog

Books, media, physical & digital resources